Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Chaetocin Exhibits Anti-Leukemia Activity Against Chronic Myeloid Leukemia Stem Cells

Catherine Hutchinson, David P. Sheridan, MD, John F. DeCoteau, MD, Ron Geyer, PhD

Blood (2012) 120 (21): 1667.

https://doi.org/10.1182/blood.V120.21.1667.1667

Published: 2012

Journal Articles

The Saskatchewan Experience for Using FCR in Treatment of CLL – A Comparison of Oral Versus IV Regimens

Richelle Dyck, Kathy Gesy, Waleed Sabry, MSc, MD, Mohamed Elemary, MD, PhD., David P. Sheridan, MD, Uthaman Moodley, MD, FRCPC, Kelsey Brose, MD, Julie Stakiw, MD

Blood (2011) 118 (21): 4613.

https://doi.org/10.1182/blood.V118.21.4613.4613

Published: 2011

Journal Articles

Stromal Cell-Derived Secreted Factors Contribute to the Innate Imatinib Resistance of Leukemia Stem Cells In a Genetically Defined Murine Model of Chronic Myeloid Leukemia Blast Crisis

C. Ronald Geyer, Michael Szeto, Ashton Craven, Marciano D. Reis, David P. Sheridan, John F. DeCoteau

Blood (2010) 116 (21): 204.

https://doi.org/10.1182/blood.V116.21.204.204

Published: 2010

Journal Articles

GNF-2, An Allosteric BCR-ABL Inhibitor, Identifies a Novel Myristoylation-Mediated Mechanism Regulating the Ability of BCR-ABL to Activate HCK and IGF-1 Signaling.

Ron Geyer, PhD, Teodora Zlateva, PhD, Asha Lakshmikuttyamma, PhD, David P. Sheridan, MD, John F. DeCoteau, MD

Blood (2009) 114 (22): 40.

https://doi.org/10.1182/blood.V114.22.40.40

Published: 2009

Journal Articles

Strategies to Re-Express Epigenetically-Silenced Tumor Suppressor Genes Converge on the Requirement for Inhibition of the Histone Methyltransferase SUV39H1.

Asha Lakshmikuttyamma, PhD, Stuart Scott, PhD, David P. Sheridan, MD, John DeCoteau, MD, Ron Geyer, PhD

Blood (2008) 112 (11): 3357.

https://doi.org/10.1182/blood.V112.11.3357.3357

Published: 2008

Journal Articles

cDNA Microarray Analysis of Genes Up-Regulated by Treatment with 5-AZA-2′-Deoxycytidine in Combination with Trichostatin A Identifies Aberrant Metallothionein 1H Promoter Methylation at a High Frequency Iin Human AML.

Stuart A. Scott, BSc, Derek S. Pearson, MD, Matthew N. Bainbridge, BSc, Wei-Feng Dong, MD, PhD, Naoto Takahashi, MD, PhD, David P. Sheridan, MD, Ryo Ichinohasama, MD, PhD, C. R. Geyer, PhD, John F. DeCoteau, MD

Blood (2004) 104 (11): 2036.

https://doi.org/10.1182/blood.V104.11.2036.2036

Published: 2004

NARROW

Chaetocin Exhibits Anti-Leukemia Activity Against Chronic Myeloid Leukemia Stem Cells

The Saskatchewan Experience for Using FCR in Treatment of CLL – A Comparison of Oral Versus IV Regimens

Stromal Cell-Derived Secreted Factors Contribute to the Innate Imatinib Resistance of Leukemia Stem Cells In a Genetically Defined Murine Model of Chronic Myeloid Leukemia Blast Crisis

GNF-2, An Allosteric BCR-ABL Inhibitor, Identifies a Novel Myristoylation-Mediated Mechanism Regulating the Ability of BCR-ABL to Activate HCK and IGF-1 Signaling.

Strategies to Re-Express Epigenetically-Silenced Tumor Suppressor Genes Converge on the Requirement for Inhibition of the Histone Methyltransferase SUV39H1.

cDNA Microarray Analysis of Genes Up-Regulated by Treatment with 5-AZA-2′-Deoxycytidine in Combination with Trichostatin A Identifies Aberrant Metallothionein 1H Promoter Methylation at a High Frequency Iin Human AML.

Email alerts

ASH Publications

American Society of Hematology

Chaetocin Exhibits Anti-Leukemia Activity Against Chronic Myeloid Leukemia Stem Cells

The Saskatchewan Experience for Using FCR in Treatment of CLL – A Comparison of Oral Versus IV Regimens

Stromal Cell-Derived Secreted Factors Contribute to the Innate Imatinib Resistance of Leukemia Stem Cells In a Genetically Defined Murine Model of Chronic Myeloid Leukemia Blast Crisis

GNF-2, An Allosteric BCR-ABL Inhibitor, Identifies a Novel Myristoylation-Mediated Mechanism Regulating the Ability of BCR-ABL to Activate HCK and IGF-1 Signaling.

Strategies to Re-Express Epigenetically-Silenced Tumor Suppressor Genes Converge on the Requirement for Inhibition of the Histone Methyltransferase SUV39H1.

cDNA Microarray Analysis of Genes Up-Regulated by Treatment with 5-AZA-2′-Deoxycytidine in Combination with Trichostatin A Identifies Aberrant Metallothionein 1H Promoter Methylation at a High Frequency Iin Human AML.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only